Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

15-Minute pharmacist talk may ease pain after pacemaker implant

NCT ID NCT06748482

Symptom relief Sponsor: Anwar Mohsen Naji Bin Ali Alhaj Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 15-minute talk with a clinical pharmacist helps people manage pain after getting a pacemaker. The pharmacist gave personalized advice on medications, side effects, and when to take pills. 60 adults who had pacemaker surgery took part. The study looked at pain episodes, medication adherence, wound infections, quality of life, and side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
clinical pharmacist consultation (behavioral intervention)
What this could lead to
If it works, this could show that a short pharmacist chat helps people control pain and take their medicines correctly after pacemaker surgery.
What could go wrong
This is a small, completed trial with only 60 people. The results may not apply to everyone, and the benefit might be small or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Oct 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have undergone pacemaker implantation surgery. * Patients \> 18 years. * The availability of smartphone with the patient or his caregiver with WhatsApp service on it. Exclusion Criteria: * Patients with a history of chronic pain. * Patients on long-term analgesic therapy. * Patients suffering from cognitive impairment or psychiatric disorders. * Pregnant women. * Patients experiencing surgical complications that may interfere with pain assessment. * Patients who refuse to participate in the study. * Illiterate patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pacemaker are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pacemaker Pain management

Contacts and locations

Locations

  • Faculty of pharmacy

    Cairo, Cairo Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.